Recent developments on dry eye disease treatment compounds. - Wikidata - awgldk - TriplyDB

Recent developments on dry eye disease treatment compounds.

Recent developments on dry eye disease treatment compounds.

http://www.wikidata.org/entity/Q37581630

about

Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics In pursuit of objective dry eye screening clinical techniques Clinical evaluation of a nutraceutical diet as an adjuvant to pharmacological treatment in dogs affected by Keratoconjunctivitis sicca Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome Preclinical mouse model to monitor live Muc5b-producing conjunctival goblet cell density under pharmacological treatments.In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants.Assessment of Tear Film Quality among Smokers Using Tear Ferning Patterns.Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment Useful In Vitro Techniques to Evaluate the Mucoadhesive Properties of Hyaluronic Acid-Based Ocular Delivery Systems A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges

P2860

Q26747001-2E0DE4D3-D348-4004-8E9C-69C2C75B4DBF Q26771221-31027185-E3FC-4078-BE5E-2D18C2B1ECC4 Q28389937-45D3735B-D03B-47D2-A74F-CF924524F3DF Q33838722-8396FA0F-EE5A-465C-8436-88B309A2D237 Q36326806-BBDB76EF-0E5A-4764-9C52-1E43AC231ABF Q39878699-E15038EF-C49B-4B0C-BC1E-25B9F9BA8E20 Q42044298-07824F46-01C6-4704-9A3C-FA1707504449 Q58702689-7EC44CAB-7326-49D4-8F5E-9277FB5E8647 Q58804205-5BE4C088-5597-4435-8971-EB71423EA004 Q59104204-351A0966-A438-45E7-965A-0FD2D88CBBCB

P2860

Recent developments on dry eye disease treatment compounds.

http://www.wikidata.org/entity/Q37581630

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Recent developments on dry eye disease treatment compounds.

@en

Recent developments on dry eye disease treatment compounds.

@nl

type

label

Recent developments on dry eye disease treatment compounds.

@en

Recent developments on dry eye disease treatment compounds.

@nl

prefLabel

Recent developments on dry eye disease treatment compounds.

@en

Recent developments on dry eye disease treatment compounds.

@nl

P1433

Q37581630-93684A87-AA74-4087-B284-ADED97E017A4

P1476

Q37581630-DE0B47D0-805D-4A0D-BDC9-C0090ED9DD9A

P2093

Q37581630-4F9FF77F-0000-4F09-B305-500F68D05224

Q37581630-5A6A6B99-F579-42CF-A78C-E4EFD9DC4EA7

Q37581630-6E2130ED-3861-415E-BBE6-54D8E1B3E863

P2860

Q37581630-01482C77-B89D-4082-8B84-EA9D14796B2F

Q37581630-0B631946-A13B-48AB-8731-2C6C5D1F4B23

Q37581630-11F723B4-817D-4028-B1F2-43B3F745FB52

Q37581630-17CE85E5-D5F3-42C3-9C8F-5959D17D0993

Q37581630-1A0DE4F3-2E7C-4876-987B-240A0B0B636B

Q37581630-1F31AE76-1B31-44B0-8516-B15DCBFC0009

Q37581630-1F5EBFCA-3228-4CE7-9B4B-C92B740B5980

Q37581630-206FFCDB-3374-4BCE-B1EC-1FA073EB7D67

Q37581630-248375B0-618D-4151-9400-50E318E7C49B

Q37581630-289C0EF2-4915-4AAF-9B15-DCCF67626E16

P304

Q37581630-3BFF3C64-07A5-4210-B6E2-310DF7CAE54B

P31

Q37581630-EB6CEE4A-4129-4C96-828A-1674AD170130

P356

Q37581630-5B47FC0E-D63B-4F0F-AD96-2265760F97D6

P433

Q37581630-F3ABD47C-8F8E-4887-ACE2-30FA577ECAB2

P478

Q37581630-619D2D39-6842-4C7E-8031-BD461A475780

P577

Q37581630-FF6F8F56-9315-4049-8346-075BEF675065

P5875

Q37581630-4678F031-F198-4A8F-A1C3-B9340C4DC14F

P698

Q37581630-377B83F8-BD3C-459D-803A-4F8898BB8F14

P932

Q37581630-BA83670D-0B74-4A78-AEC3-2CBF5A505179

P356

J.SJOPT.2013.12.003

P1433

Saudi journal of ophthalmology

P1476

Recent developments on dry eye disease treatment compounds.

@en

P2093

Basilio Colligris

http://www.w3.org/2001/XMLSchema#string

Hanan Awad Alkozi

http://www.w3.org/2001/XMLSchema#string

Jesus Pintor

http://www.w3.org/2001/XMLSchema#string

P2860

Evolutionary divergence and functions of the human interleukin (IL) gene family

ZAP70: a master regulator of adaptive immunity

Essential role for ZAP-70 in both positive and negative selection of thymocytes

Lacritin and the tear proteome as natural replacement therapy for dry eye

Fate mapping of IL-17-producing T cells in inflammatory responses

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases

MMP-9 and the perioperative management of LASIK surgery.

Cytokine receptor signaling pathways.

P304

19-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SJOPT.2013.12.003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259322957

http://www.w3.org/2001/XMLSchema#string

P698

24526854

http://www.w3.org/2001/XMLSchema#string

P932

3923205

http://www.w3.org/2001/XMLSchema#string